Works by Dai, Hengfen

Results: 17

Prevalence, risk characteristics, and prediction of low-dose edoxaban treatment in hospitalized patients: a multicenter, observational cohort study.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1427634

By:

Zhao, Shujuan;
Dai, Hengfen;
Chen, Jiaxin;
Ni, Ming;
Peng, Wenxing;
Li, Xiaoyu;
Li, Fen;
Chen, Boya;
Cai, Haixia;
Liu, Yinping;
Du, Song

Publication type:

Article

Association between Body Mass Index and Clinical Outcomes in Patients with Non-valvular Atrial Fibrillation Receiving Direct Oral Anticoagulants: A New Piece of Evidence on the Obesity Paradox from China.

Published in:

Cardiovascular Drugs & Therapy, 2023, v. 37, n. 4, p. 715, doi. 10.1007/s10557-022-07332-0

By:

Wu, Shuyi;
Huang, Nianxu;
Chen, Xia;
Jiang, Shaojun;
Zhang, Wang;
Hu, Wei;
Su, Jun;
Dai, Hengfen;
Gu, Ping;
Huang, Xiaohong;
Du, Xiaoming;
Li, Ruijuan;
Zheng, Qiaowei;
Lin, Xiangsheng;
Zhang, Yanxia;
Zou, Lang;
Liu, Yuxin;
Zhang, Min;
Liu, Xiumei;
Zhu, Zhu

Publication type:

Article

Effects of intensive, targeted education by pharmacists on anticoagulant patients with atrial fibrillation: a multicentre randomized controlled trial from China.

Published in:

European Journal of Cardiovascular Nursing, 2024, v. 23, n. 8, p. 935, doi. 10.1093/eurjcn/zvae092

By:

Xu, Wenlin;
Wu, Tingting;
Chen, Jiana;
Lv, Meina;
Wang, Na;
Qiu, Sha;
Dai, Hengfen;
Hu, Wei;
Chen, Pei;
Li, Meijuan;
Li, Li;
Zhang, Feilong;
Chang, Sijie;
Zhang, Jinhua

Publication type:

Article

Zeta Inhibitory Peptide as a Novel Therapy to Control Chronic Visceral Hypersensitivity in a Rat Model.

Published in:

PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0163324

By:

Tang, Ying;
Chen, Aiqin;
Chen, Yu;
Guo, Lixia;
Dai, Hengfen;
Huang, Yang;
Chen, Qianqian;
Lin, Chun

Publication type:

Article

Efficacy and Safety of Direct Oral Anticoagulants in Patients With Atrial Fibrillation Combined With Hypertension: A Multicenter, Retrospective Cohort Study.

Published in:

Journal of Clinical Pharmacology, 2023, v. 63, n. 8, p. 895, doi. 10.1002/jcph.2246

By:

Guan, Chengfu;
Xu, Wenlin;
Lv, Meina;
Wu, Tingting;
Chen, Xia;
Zhang, Wang;
Huang, Nianxu;
Dai, Hengfen;
Gu, Ping;
Huang, Xiaohong;
Du, Xiaoming;
Li, Ruijuan;
Zheng, Qiaowei;
Lin, Xiangsheng;
Liu, Yuxin;
Zhang, Min;
Liu, Xiumei;
Zhu, Zhu;
Zhang, Jinhua

Publication type:

Article

Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study.

Published in:

Thrombosis Journal, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12959-023-00563-7

By:

Xu, Wenlin;
Chen, Jiana;
Wu, Shuyi;
Huang, Nianxu;
Chen, Xia;
Zhang, Wang;
Hu, Wei;
Su, Jun;
Dai, Hengfen;
Gu, Ping;
Huang, Xiaohong;
Du, Xiaoming;
Li, Ruijuan;
Zheng, Qiaowei;
Lin, Xiangsheng;
Zhang, Yanxia;
Zou, Lang;
Liu, Yuxin;
Zhang, Min;
Liu, Xiumei

Publication type:

Article

Safety and efficacy of direct oral anticoagulation in patients with and without radiofrequency ablation of non-valvular atrial fibrillation: a multicenter retrospective cohort study.

Published in:

Thrombosis Journal, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12959-023-00483-6

By:

Wu, Shuyi;
Guan, Chengfu;
Xu, Wenlin;
Zhang, Feilong;
Huang, Nianxu;
Chen, Xia;
Zhang, Wang;
Hu, Wei;
Su, Jun;
Dai, Hengfen;
Gu, Ping;
Huang, Xiaohong;
Du, Xiaoming;
Li, Ruijuan;
Zheng, Qiaowei;
Lin, Xiangsheng;
Zhang, Yanxia;
Zou, Lang;
Liu, Yuxin;
Zhang, Min

Publication type:

Article

Effects of sodium‐glucose cotransporter type 2 inhibitors on cardiovascular, renal, and safety outcomes in patients with cardiovascular disease: a meta‐analysis of randomized controlled trials.

Published in:

2021

By:

Zheng, Caiyun;
Lin, Meimei;
Chen, Yan;
Xu, Haiting;
Yan, Lingqun;
Dai, Hengfen

Publication type:

Literature Review

Prevalence, contemporary trends and associated factors of potentially inappropriate prescription of edoxaban in real‐world clinical practice: A subanalysis of the SUNSHINE registry.

Published in:

British Journal of Clinical Pharmacology, 2024, v. 90, n. 3, p. 837, doi. 10.1111/bcp.15961

By:

Zhao, Shujuan;
Dai, Hengfen;
Chen, Jiaxin;
Ni, Ming;
Peng, Wenxing;
Li, Xiaoyu;
Li, Fen;
Chen, Boya;
Cai, Haixia;
Liu, Yinping;
Gu, Zhichun;
Du, Song;
Ma, Peizhi

Publication type:

Article

Blockade of BDNF signalling attenuates chronic visceral hypersensitivity in an IBS-like rat model.

Published in:

2020

By:

Fan, Fei;
Tang, Ying;
Dai, Hengfen;
Cao, Yang;
Sun, Pei;
Chen, Yu;
Chen, Aiqin;
Lin, Chun

Publication type:

journal article

MiRNA-1202 promotes the TGF-β1-induced proliferation, differentiation and collagen production of cardiac fibroblasts by targeting nNOS.

Published in:

PLoS ONE, 2021, v. 16, n. 8, p. 1, doi. 10.1371/journal.pone.0256066

By:

Xiao, Jingwen;
Zhang, Yan;
Tang, Yuan;
Dai, Hengfen;
OuYang, Yu;
Li, Chuanchuan;
Yu, Meiqin

Publication type:

Article

Efficacy and safety of direct oral anticoagulants for preventing venous thromboembolism in hospitalized cancer patients: a national multicenter retrospective cohort study.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1373635

By:

Shuyi Wu;
Haiping Wang;
Chunbao Li;
Jingjing Tao;
Xiaoli Zhu;
Hengfen Dai;
Hongfan Duan;
Tian Hu;
Miao Li;
Fenfen Qu;
Yun Wei;
Chunhua Wang;
Jinhua Zhang

Publication type:

Article

Correction: Technology-Based Interventions in Oral Anticoagulation Management: Meta-Analysis of Randomized Controlled Trials.

Published in:

2020

By:

Dai, Hengfen;
Zheng, Caiyun;
Lin, Chun;
Zhang, Yan;
Zhang, Hong;
Chen, Fan;
Liu, Yunchun;
Xiao, Jingwen;
Chen, Chaoxin

Publication type:

corrected article

Technology-Based Interventions in Oral Anticoagulation Management: Meta-Analysis of Randomized Controlled Trials.

Published in:

2020

By:

Zheng, Caiyun;
Dai, Hengfen;
Lin, Chun;
Zhang, Yan;
Zhang, Hong;
Chen, Fan;
Liu, Yunchun;
Xiao, Jingwen;
Chen, Chaoxin

Publication type:

journal article

hsa-miR-4443 inhibits myocardial fibroblast proliferation by targeting THBS1 to regulate TGF-β1/α-SMA/collagen signaling in atrial fibrillation.

Published in:

Brazilian Journal of Medical & Biological Research, 2021, v. 54, n. 4, p. 1, doi. 10.1590/1414-431X202010692

By:

Jingwen Xiao;
Yan Zhang;
Yuan Tang;
Hengfen Dai;
Yu OuYang;
Chuanchuan Li;
Meiqin Yu

Publication type:

Article

Application of Alfalfa App in the management of oral anticoagulation in patients with atrial fibrillation: a multicenter randomized controlled trial.

Published in:

BMC Medical Informatics & Decision Making, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12911-024-02701-1

By:

Xu, Wenlin;
Huang, Xinhai;
Lin, Qiwang;
Wu, Tingting;
Guan, Chengfu;
Lv, Meina;
Hu, Wei;
Dai, Hengfen;
Chen, Pei;
Li, Meijuan;
Zhang, Feilong;
Zhang, Jinhua

Publication type:

Article

Efficacy and safety of dabigatran and rivaroxaban in atrial fibrillation patients with impaired liver function: a multicenter retrospective cohort study.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 8, p. 1141, doi. 10.1007/s00228-024-03689-3

By:

Huang, Xinhai;
Xu, Wenlin;
Wu, Guilan;
Li, Ruijuan;
Gu, Ping;
Zheng, Qiaowei;
Liu, Xiumei;
Dai, Hengfen;
Lin, Xiangsheng;
Liu, Yuxin;
Du, Xiaoming;
Su, Jun;
Zhang, Wang;
Zhang, Min;
Zhu, Zhu;
Huang, Xiaohong;
Huang, Nianxu;
Zhang, Jinhua

Publication type:

Article